2023년 10월 12일 10:08

FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial

Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial. The inspection resulted in no FDA Form 483 obs...